A select group of plaintiffs recently asked to consolidate the Xarelto lawsuits as part of a federal multidistrict litigation (MDL) to streamline the litigation process, coordinate discovery, and set bellwether trials to determine the strength of the claims.
In response thereto and pursuant to the federal rules, the U.S. Judicial Panel on Multidistrict Litigation recently issued an order sending all federally filed Xarelto cases to the experienced U.S. District Judge Eldon E. Fallon in Eastern District of Louisiana.
What is Xarelto?
Xarelto is a new generation anticoagulant developed by Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary in 2011 as a superior alternative to warfarin (Coumadin), the blood thinner used widely since the 1950s for the prevention of strokes.
Xarelto is prescribed to patients suffering from atrial fibrillation (irregular heart beat) who are at increased risk of formed a blood clot in the heart, which can travel to the brain and cause a stroke. Xarelto thins the blood and lowers the chance of clots forming.
Although all blood thinners may increase the risk of bleeding problems, Xarelto has been linked to an increased number of uncontrollable blood injuries, in part because there is no approved and/or viable antidote available for patients who use Xarelto. Many of the side effects have been severe and even fatal because the bleeding cannot be effectively controlled or stopped when needed. The effects of Coumadin, on the other hand, can be quickly reversed with the use of vitamin K, frozen plasma and/or blood transfusions in the event of an emergency.
There are currently 50 product liability lawsuits pending in the federal system and another 75 in the state court concerning Xarelto, an anticoagulant with hundreds deaths being attributed to its side effects. According to the complaints, the drug’s manufacturers failed to warn consumers about the potential side effects of Xarelto, which include uncontrollable bleeding that can lead to hospitalization, blood transfusions, and in some cases, even death.
Court documents allege that the injuries and deaths would have been avoided had stronger warnings been provided about the lack of a Xarelto reversal agent or antidote.
If you or a loved one has suffered serious, uncontrollable bleeding while on Xarelto, you should speak with Childers, Schlueter & Smith today. Our Xarelto lawyers, headed up by firm partner Andy Childers, will provide a free initial case evaluation and consultation to educate you more about your legal rights and options.